Skip to main content
Maura Boldrini, MD, Psychiatry, New York, NY

Maura Boldrini MD PhD


Professor of Psychiatry

Request Appointment
  • 3 Columbus CircleNew York, NY 10019

  • Book by Phone+1(251) 250-4274

Overview of  Dr. Boldrini

Dr. Maura Boldrini is a psychiatrist in New York, NY and is affiliated with multiple hospitals in the area, including New York-Presbyterian Hospital and NewYork-Presbyterian/Columbia University Irving Medical Center. She received her medical degree from University of Pisa Faculty of Medicine and has been in practice 25 years. She is one of 948 doctors at New York-Presbyterian Hospital and one of 326 doctors at NewYork-Presbyterian/Columbia University Irving Medical Center who specialize in Psychiatry. She also speaks multiple languages, including Italian. She has more than 40 publications and over 500 citings.

Education & Training

  • New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric Institute
    New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteResidency, Psychiatry, 2014 - 2020
  • New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric Institute
    New York Presbyterian Hospital (Columbia Campus)/New York State Psychiatric InstituteResidency, Psychiatry, 2015 - 2019
  • University of Pisa Faculty of Medicine
    University of Pisa Faculty of MedicineClass of 1994

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2024 - 2027
  • NY State Medical License
    NY State Medical License 2019 - 2026
  • CT State Medical License
    CT State Medical License 2018 - 2020
  • Psychiatry
    American Board of Psychiatry and Neurology Psychiatry

Publications & Presentations

PubMed

Journal Articles

  • How COVID-19 Affects the Brain  
    Maura Boldrini, MD, JAMA Psychiatry

Press Mentions

  • Newborn Cells in the Epileptic Brain Provide a Potential Target for Anti-Seizure Medications
    Newborn Cells in the Epileptic Brain Provide a Potential Target for Anti-Seizure MedicationsApril 5th, 2022
  • Covid-19 Patients May Have Increased Risk of Developing Mental Health Problems
    Covid-19 Patients May Have Increased Risk of Developing Mental Health ProblemsFebruary 17th, 2022
  • People Were 41% More Likely to Have Sleep Disorders After Getting COVID-19, a Large Study Found
    People Were 41% More Likely to Have Sleep Disorders After Getting COVID-19, a Large Study FoundFebruary 17th, 2022
  • Join now to see all

Grant Support

  • Human brain multi-omics to decipher major depression pathophysiologyNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2023–2028
  • Comparison of normal aging with Alzheimer's Disease: cellular, synaptic, and vascular indices affecting brain plasticity and neurogenesisNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2023–2028
  • Comparison of normal aging with Alzheimer's Disease: cellular, synaptic, and vascular indices affecting brain plasticity and neurogenesisNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2023–2028
  • New technologies to identify molecular regulators of the human hippocampus neurogenic niche in healthy aging and Alzheimer's DiseaseNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2022–2027
  • How the Novel Coronavirus Attacks the BrainNEW YORK STATE PSYCHIATRIC INSTITUTE DBA RESEARCH FOUNDATION FOR MENTAL HYGIENE, INC2021–2025

Other Languages

  • Italian

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: